These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 14105973)

  • 1. [STUDIES ON TESTS FOR THE NON-TOXICITY OF INACTIVATED POLIOMYELITIS VACCINES. 1. INFLUENCE OF MAGNESIUM CHLORIDE ON THE SUSCEPTIBILITY OF MONKEY KIDNEY CELL CULTURES TO FORMALIN-TREATED POLIOMYELITIS VIRUS].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Nov; 190():313-21. PubMed ID: 14105973
    [No Abstract]   [Full Text] [Related]  

  • 2. REACTION OF POLIOVIRUS AND FORMALDEHYDE IN MAGNESIUM CHLORIDE SOLUTION TO ENHANCE POTENCY OF KILLED-VIRUS VACCINE.
    OZAKI Y; MELNICK JL
    J Immunol; 1963 Mar; 90():429-37. PubMed ID: 14051877
    [No Abstract]   [Full Text] [Related]  

  • 3. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE MONKEY VIRUS SV 40 IN POLIOMYELITIS VACCINE TESTS].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 191():83-9. PubMed ID: 14119946
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum inhibition of cytopathic effect and virus release of type 3 poliovirus vaccine in primary monkey-kidney (MK) cultures.
    ORSI EV; MESSORE G; LEVINE S; ROCA-GARCIA M
    Am J Hyg; 1961 May; 73():282-93. PubMed ID: 13731294
    [No Abstract]   [Full Text] [Related]  

  • 6. INTRATYPIC SERODIFFERENTIATION TESTS ON POLIO TYPE 1 VIRUS STRAINS ISOLATED BEFORE AND AFTER VACCINATION WITH ATTENUATED SABIN TYPE 1 POLIO VACCINE.
    HAHNEMANN F; SIBONI K; GODTFREDSEN A
    Acta Pathol Microbiol Scand; 1964; 61():437-45. PubMed ID: 14164891
    [No Abstract]   [Full Text] [Related]  

  • 7. THE COMPLEMENT FIXATION REACTION FOR MEASUREMENT OF IMMUNOGENIC ANTIGENS IN FORMALDEHYDE-INACTIVATED POLIOMYELITIS VACCINE.
    MACMORINE HG; WARDLAW AC; WEBER JC
    J Immunol; 1965 Apr; 94():611-21. PubMed ID: 14299037
    [No Abstract]   [Full Text] [Related]  

  • 8. [METHODS AND RESULTS OF PREPARATION OF LIVE POLIOMYELITIS VACCINE, NOT CONTAINING MIXTURES OF VACUOLIZING VIRUS (OB40-SV40)].
    CHUMAKOV MP; DZAGUROV SG; LASHKEVICH VA; GRACHEV VP; MIRONOVA LL; RALF NM; ELBERT LB
    Vopr Virusol; 1963; 29():445-9. PubMed ID: 14071282
    [No Abstract]   [Full Text] [Related]  

  • 9. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINE. III. IS THERE INTERFERENCE BY SV 40 AGAINST POLIOVIRUS?].
    GUENTHER O; VON METTENHEIM ; HOEVEL H
    Zentralbl Bakteriol Orig; 1964 Feb; 192():1-11. PubMed ID: 14176847
    [No Abstract]   [Full Text] [Related]  

  • 10. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. I. STUDIES ON TYPE 1 STRAINS.
    FURESZ J; ARMSTRONG RE; YAROSH W; NAGLER FP
    Am J Hyg; 1964 Jul; 80():45-54. PubMed ID: 14192769
    [No Abstract]   [Full Text] [Related]  

  • 11. PRESERVATIVES FOR POLIOMYELITIS (SALK) VACCINE. II. FORMALDEHYDE AND ESTERS OF P-HYDROXYBENZOIC ACID.
    TRACY JM; GLASS DG; NICHOLSON MJ; PIVNICK H
    J Pharm Sci; 1964 Jun; 53():659-63. PubMed ID: 14198442
    [No Abstract]   [Full Text] [Related]  

  • 12. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. II. STUDIES ON TYPE 3 STRAINS.
    FURESZ J; ARMSTRONG RE; MOREAU P; NAGLER FP
    Am J Hyg; 1964 Jul; 80():55-61. PubMed ID: 14192770
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on safety tests of inactivated poliomyelitis vaccines. IV. Comparative safety tests in rhesus monkeys and long-tailed monkeys (Cercopithecus aethiops)].
    Günther O; Hövel H; von Mettenheim A; Burde K; Heber L; Unterharnscheidt F
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):137-50. PubMed ID: 4296870
    [No Abstract]   [Full Text] [Related]  

  • 14. Magnesium chloride enhancement of cell susceptibility to poliovirus.
    WALLIS C; MELNICK JL
    Virology; 1962 Feb; 16():122-32. PubMed ID: 14004707
    [No Abstract]   [Full Text] [Related]  

  • 15. Present state and developments in the production of inactivated poliomyelitis vaccine.
    van Wezel AL
    Dev Biol Stand; 1981; 47():7-13. PubMed ID: 6262162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum inhibition of cytopathic effect and virus release of type 3 poliovirus vaccine in primary monkey-kidney (MK) cultures. II. Influence of temperature.
    ORSI EV; MESSORE G
    Am J Hyg; 1963 Jan; 77():73-81. PubMed ID: 13940407
    [No Abstract]   [Full Text] [Related]  

  • 17. DEXTRAN SULFATE PLAQUE VARIANTS OF ATTENUATED TYPE 1 POLIOVIRUS. RELATIONSHIP TO IN VITRO AND IN VIVO MARKERS.
    TAKEMOTO KK; KIRSCHSTEIN RL
    J Immunol; 1964 Feb; 92():329-33. PubMed ID: 14160455
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on safety tests of inactivated poliomyelitis vaccines. VI. On the effect of cortisone in monkey experiments].
    Günther O; Unterharnscheidt F; Hövel H
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):166-79. PubMed ID: 4967641
    [No Abstract]   [Full Text] [Related]  

  • 19. THE CUTTER INCIDENT. POLIOMYELITIS FOLLOWING FORMALDEHYDE- INACTIVATED POLIOVIRUS VACCINATION IN THE UNITED STATES DURING THE SPRING OF 1955. II. RELATIONSHIP OF POLIOMYELITIS TO CUTTER VACCINE.
    NATHANSON N; LANGMUIR AD
    Am J Hyg; 1963 Jul; 78():29-60. PubMed ID: 14043545
    [No Abstract]   [Full Text] [Related]  

  • 20. The susceptibility of monkey kidney cells to poliovirus in vivo and in vitro.
    KAPLAN AS
    Virology; 1955 Nov; 1(4):377-92. PubMed ID: 13274739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.